Japanese Logistics Stock News

Takashimaya Company (TSE:8233) has revised its earnings guidance for the fiscal year ending February 28, 2026, and now expects a loss attributable to owners of the parent after finalizing a large extraordinary loss on bond cancellation. See our latest analysis for Takashimaya Company. The guidance revision comes after a sharp 17.47% 1 month share price decline, even though the 1 year total shareholder return of 57.01% and 5 year total shareholder return of 230.47% point to strong longer term...

Illumination and Nintendo Co., Ltd. recently unveiled the final trailer for The Super Mario Galaxy Movie during a Nintendo Direct, confirming an April 2026 global theatrical rollout with an ensemble voice cast including Chris Pratt, Anya Taylor-Joy, Jack Black, and Donald Glover as Yoshi. By expanding its Mario universe on the big screen with returning filmmakers and fresh celebrity talent, Nintendo is deepening its entertainment IP footprint beyond gaming and creating new ways to connect...

In early March 2026, SoftBank Corp. outlined its Telco AI Cloud vision, shifting from a traditional telecom carrier to an AI-native infrastructure provider that embeds distributed AI processing across data centers, radio networks, and edge environments, with partners including Ericsson, Yaskawa Electric, Mitsubishi Heavy Industries, Northeastern University, Keysight, and zTouch Networks. By turning the network into a computation layer for “Physical AI” and open-sourcing core AI-RAN...

Event context and recent performance snapshot With no specific catalyst driving headlines today, Advantest (TSE:6857) is drawing attention for its recent share performance. The stock has moved 4.7% over the past day and declined 6.9% over the past week. See our latest analysis for Advantest. That 4.7% 1 day share price move comes after a softer patch, with a 7 day share price return of 6.9% and a 30 day share price return of 2.3%. However, the 90 day share price return of 18.9% sits alongside...

Cowellnex, Kyowa Kirin and Metagen have begun joint research to develop gut microbiota tests and personalized food recommendation algorithms for Japanese individuals, using Cowellnex’s high-precision shotgun metagenomic data accumulated over roughly three years. The collaboration highlights how advanced microbiome analytics could underpin new personalized gut health services, potentially expanding Kirin’s reach in science-based health and nutrition solutions. Next, we’ll examine how this...

NTT (TSE:9432) is back in the spotlight after announcing that it will showcase its Innovative Optical and Wireless Network (IOWN) and photonics based infrastructure at MWC Barcelona 2026, focusing on AI, networking and energy efficiency. See our latest analysis for NTT. NTT’s latest AI and photonics push at MWC comes after a mixed stretch for the shares, with a 1-year total shareholder return of 8.12%, a year to date share price return of 3.45% and a 5-year total shareholder return of 59.16%...

GMO Internet Group recently held a board meeting to consider establishing an investment limited partnership as a subsidiary, while confirming a refreshed slate of group executive officers, including Founder, Chairman and Group CEO Masatoshi Kumagai and new group executive officer Tatsuki Yamamoto, CFO of GMO Financial Holdings. This combination of governance refinement and potential new investment vehicle highlights management’s focus on tightening oversight across financial services and...

Why Mazda Motor drew fresh attention Mazda Motor (TSE:7261) is back on investors’ radar after recent share price moves, with the stock showing a mix of short term pressure and steadier longer term total returns. See our latest analysis for Mazda Motor. The recent 1-day share price return of a 5.12% decline and 7-day share price return of a 15.87% decline contrast with a 1-year total shareholder return of 16.59%, so short-term momentum appears weaker even as longer-term holders remain...

Shimano (TSE:7309) is back in the spotlight after two shareholder focused moves: a proposed higher year end dividend for fiscal 2025 and a rejected call for a large, rapid share buyback. See our latest analysis for Shimano. These dividend and buyback debates come after a tougher period for shareholders, with a 1 year total shareholder return of 22.5% decline and a 5 year total shareholder return of 28.9% decline, while the 1 month share price return of 11.3% decline suggests recent momentum...

Why Nissan Chemical (TSE:4021) Is Back on Investors’ Radar Nissan Chemical (TSE:4021) has drawn attention after announcing broad senior management changes effective April 1, 2026, alongside a board decision to cancel a portion of its own shares, bringing governance and capital allocation into focus. See our latest analysis for Nissan Chemical. The latest senior appointments and the planned share cancellation arrive after a 90 day share price return of 19.95% and a 1 year total shareholder...

Earnings setback puts Ito En’s recent share performance in focus Ito En (TSE:2593) recently reported nine month earnings to January 31, 2026, with sales of ¥379,477 million and a net loss of ¥88 million, compared with net income a year earlier. See our latest analysis for Ito En. The earnings setback appears to be weighing on sentiment, with a 30 day share price return decline of 3.06% and a year to date share price return decline of 2.77%, while the 5 year total shareholder return decline of...

Air Water (TSE:4088) is back in focus as investors position ahead of its Q4 earnings release, with attention on EPS, operating cash flow, and any commentary on hydrogen and medical supply contracts. See our latest analysis for Air Water. Despite renewed attention ahead of Q4 earnings, Air Water’s 1 month share price return of -16.13% to ¥2,031 contrasts with a 1 year total shareholder return of 8.95%, hinting at fading short term momentum versus still positive longer term outcomes. If this...

Sumitomo Pharma (TSE:4506) just secured conditional Japanese approval for AMCHEPRY, an iPS cell based Parkinson’s therapy, alongside raising its fiscal 2026 earnings guidance and considering a new share issuance, putting the stock firmly on investors’ radar. See our latest analysis for Sumitomo Pharma. The conditional AMCHEPRY approval and raised fiscal 2026 guidance arrive after a volatile period, with a 1 year total shareholder return of 174.36% contrasting with a weaker recent 7 day share...

In early March 2026, Roundhill Investments launched the actively managed Roundhill Space & Technology ETF (MARS), naming SKY Perfect JSAT Holdings as one of its top holdings while the company also reported 27,266 net customer additions in February for its satellite communication and broadcasting services. This combination of ETF inclusion and fresh subscriber growth highlights SKY Perfect JSAT’s role as a key participant in the commercial space and satellite communications ecosystem. We’ll...

Sumitomo Mitsui Financial Group, Inc. recently held a board meeting that approved the appointment of Takeshi Mikami as Deputy President and Representative Executive Officer, effective April 1, 2026, as part of a broader management reshuffle. This leadership change arrives alongside recent capital-raising through US$1.25 billion of fixed-to-floating rate notes, underscoring how governance and funding decisions may shape the group’s future priorities. Next, we will examine how the...

TBS HOLDINGS, CJ ENM and U-NEXT HOLDINGS Ltd (TSE:9418) have agreed to form a joint venture in Japan to plan, invest in and develop audio visual content IPs across Japanese and Korean markets. See our latest analysis for U-NEXT HOLDINGSLtd. U-NEXT HOLDINGS Ltd’s share price has eased this year, with a 1-day share price return of 0.68% contrasting with a 90-day share price return decline of 7.99%. Its 5-year total shareholder return of 180.51% points to strong long-term compounding and...

ANYCOLOR Inc. recently reported a Q4 earnings beat, with management pointing to stronger content, subscription, and merchandising revenues as key drivers of the outperformance. An interesting takeaway from the results is how improved monetization of NIJISANJI-related content and events appears to be strengthening the company’s overall profitability profile. With recent share gains, we will examine how stronger content monetization and subscription growth could shape ANYCOLOR’s investment...

Why Terumo’s new cell and gene therapy blueprint matters for shareholders Terumo (TSE:4543) is drawing attention after its Blood and Cell Technologies unit introduced a C> Ecosystem Blueprint to support cell and gene therapy developers in Asia Pacific, focusing on workflows, capabilities, and collaborative partnerships. See our latest analysis for Terumo. Terumo’s 1 day share price return of 4.33% to ¥2,061 comes after a period of weaker momentum, with a 90 day share price return of 13.02%...

Rakuten Group (TSE:4755) is back in focus after announcing that Group CFO, Director, and Group Executive Vice President Kenji Hirose will retire on March 27, 2026, alongside renewed talks on reorganizing its FinTech business. See our latest analysis for Rakuten Group. At a share price of ¥805.3, Rakuten Group has a 1-day share price return of 2.83%. Its 30-day and year to date share price returns of 14.63% and 19.79% declines suggest momentum has cooled. This is occurring even though the...

TBS Holdings Inc (TSE:9401) has signed a joint venture agreement with CJ ENM and U-NEXT Holdings to build a global IP creation framework, aligning with its Medium-Term Business Plan 2026 content ambitions. See our latest analysis for TBS HoldingsInc. The joint venture news lands at a time when TBS HoldingsInc’s 1-month share price return of 5.07% and 90-day share price return of 3.95% sit alongside a 1-year total shareholder return of 38.19%, pointing to momentum that has been building over...

In early March 2026, Sumitomo Pharma secured conditional Japanese approval for AMCHePRY, the world’s first iPS cell-derived regenerative therapy for Parkinson’s disease patients whose symptoms are not adequately controlled by existing drugs, while also raising its full-year revenue and profit guidance, helped by stronger GEMTESA sales in North America and a weaker yen. The company’s decision on the same day to prepare a shelf registration for potential new share issuance, alongside its...

Positive Phase 3 data for PADCEV plus Keytruda in muscle invasive bladder cancer has put Astellas Pharma (TSE:4503) in focus, as investors weigh what the EV-304 results could mean for its oncology franchise. See our latest analysis for Astellas Pharma. The positive EV-304 update lands after a 19.78% 90 day share price return and a 12.86% year to date share price return, alongside a 73.33% 1 year total shareholder return that points to strong ongoing momentum. If this oncology news has you...

If you are wondering whether Kyocera's share price still reflects good value, this article walks through what the numbers actually say about the stock. Kyocera shares last closed at ¥2,641, with returns of 2.3% over 30 days, 18.4% year to date, 59.6% over 1 year, 66.6% over 3 years and 61.9% over 5 years, despite a 4.4% decline in the last 7 days. Recent coverage has focused on Kyocera's position in the broader tech sector and how investors are reassessing established manufacturers in light...

SoftBank unveiled its Telco AI Cloud vision, outlining a shift from traditional telecom carrier to AI-native infrastructure provider. The company showed AI-enabled networking and AI-RAN use cases with partners including Yaskawa Electric, Ericsson, and Mitsubishi Heavy Industries. SoftBank plans to support distributed AI and edge computing and is open-sourcing core AI orchestration technology to encourage wider industry adoption. For investors watching TSE:9434, this move comes as SoftBank...